XSHE
002799
Market cap345mUSD
Oct 09, Last price
7.27CNY
1D
0.69%
1Q
19.38%
Jan 2017
-63.56%
IPO
44.82%
Name
XiAn Global Printing Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in 2001 and headquartered in Xi'an, China, Xi'an Global Printing Co., Ltd. delivers extensive packaging solutions to pharmaceutical companies both within China and globally. The firm supplies a variety of packaging materials, including pharmaceutical folding cartons, informational leaflets, and aluminum tubes, alongside comprehensive service strategies for these products. Its offerings are utilized across a broad spectrum of items, ranging from over-the-counter and prescription medications to health and wellness products, medical devices, traditional herbal remedies, and cosmetic goods.
Key people
Yiling Li
Chairman of the Board
Xuejun Sun
General Manager, Director
Ming Xu
Deputy General Manager
Jianping Zhao
Deputy General Manager
Wei Lin
Finance Director, Chief Accounting Officer, Secretary of the Board
Hongjun Cai
Director
Jun Yang
Director
Junke Feng
Independent Director
Songquan Wen
Independent Director
Mingyu Zhang
Independent Director
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||